GL1X · GenesisL1 explorer

Research workbench

A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site

Analyse A novel serine protease inhibition motif involving a multi-centered short… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1GI8
Type
protein
Length
254 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Urokinase-type plasminogen activator
EC
3.4.21.73
UniProt
P00749
Ligands
BMZ
Pockets
1 · best druggability 0.41

Structure

x-ray diffraction · 2 distinct chains · 10% helix, 38% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AUrokinase-type plasminogen activatorprotein90% helix, 0% strandP00749
BUrokinase-type plasminogen activator (EC 3.4.21.73)protein24511% helix, 39% strandP00749

Ligands and binding sites

  • BMZ · 2-(2-hydroxy-phenyl)-1H-benzoimidazole-5-carboxamidine · ligand · chains B
  • CIT · Citric acid · additive · 2 copies · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11320.410.7530BMZ

Interfaces

1 interface between chains.

  • A–B · 472 Ų buried · 7 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 disulfide (disulfide).

Compared structures

  • 1GI8 · A novel serine protease inhibition motif involving a multi-centered short hydrogen… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.